Triflufenacil is a new type of SDHI fungicide and has broad room for future development.

Triflufenac (trade names: Adepidyn, Miravis, etc.) is a new pyridinamide fungicide that acts on succinate dehydrogenase (SDHI). Tricarboxylic acid is a respiratory inhibitor of pathogenic bacteria. It acts on the succinate dehydrogenase in bacteria and interferes with the tricarboxylic acid cycle to hinder their energy metabolism, thereby inhibiting the growth of pathogenic bacteria and causing their death.

Triflufenac was successfully developed by Syngenta Group and was successfully launched in Argentina in 2017. In 2020, Triflufenac successfully entered the Chinese market. Triflufenac is the best product among Syngenta Group’s SDHI fungicides and one of the fastest-growing SDHI fungicides in the world. In the first half of 2021, Syngenta Group’s performance has achieved steady growth. Hydroxylamine performed strongly, and the demand for tritrifenpyramide has increased significantly in areas where extreme weather frequently occurs.

According to the “China Triflufenac Industry Market In-depth Assessment and 2022-2026 Investment Feasibility Consultation Report released by the Industrial Research Center 》 shows that triflufenac has the characteristics of broad spectrum, high efficiency, long-lasting and stable. As a new fungicide ingredient, triflufenac has been on the market for a short time in China and there is no bacterial resistance. Therefore, it has great advantages in China. Larger development space. In 2021, the global sales of triflufenac will be around US$300 million. From 2020 to 2021, the demand for triflufenac in the Chinese market will grow rapidly, and my country will also become a driver of Syngenta Group’s triflufenac operating income. One of the important drivers of growth.

Triflufenac has a broad spectrum and can be used to prevent and control powdery mildew, leaf spot, net spot, moire, etc. caused by pathogenic bacteria such as Fusarium, Cercospora, and Alternaria. It is suitable for crops including cereals, rice, Vegetables, peanuts, rapeseed, melons, etc. Under the active layout of Syngenta Group, triflufenac has been registered and marketed in more than 50 countries including South Korea, Japan, the United States, Canada, and China, and its dosage forms include suspensions, seed treatment suspensions, and suspoemulsions.

Syngenta Group’s patented compound triflufenac will expire in my country in 2029. In China, the registered industries of triflufenac are 98% tritrifenac technical product, 200 g/L difenoconazole + triflufenac suspension, and 200 g/L triflufenac suspension. , 400 g/L triflufenac + fludioxonil suspension, etc., of which 200 g/L triflufenac and fludioxonil suspension and 200 g/L difenoconazole + fludioxonil suspension are in the market The most common.

Industry analysts said that triflufenac is a new type of SDHI fungicide. Currently, triflufenac has been used in many countries around the world. It has been approved for marketing in several countries and regions, among which areas with frequent extreme weather have higher demand for triflufenac. With the characteristics of high efficiency, broad spectrum, durability and stability, the global sales of triflufenac are growing continuously, and it is expected that the annual sales of triflufenac are expected to exceed US$1 billion in the future.